9,10-dimethyl-1,2-benzanthracene has been researched along with diosmin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciolino, HP; Wang, TT; Yeh, GC | 1 |
| Rajasekar, M; Sivakumar, K; Suresh, K | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and diosmin
| Article | Year |
|---|---|
Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Carcinogens; Cytochrome P-450 CYP1A1; Diosmin; DNA Adducts; Dose-Response Relationship, Drug; Flavonoids; Humans; Receptors, Aryl Hydrocarbon; RNA, Messenger; Tumor Cells, Cultured | 1998 |
Diosmin induce apoptosis through modulation of STAT-3 signaling in 7,12 dimethylbenz(a)anthracene induced harmster buccal pouch carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Biomarkers, Tumor; Body Weight; Carcinogenesis; Cell Proliferation; Cricetinae; Diosmin; Male; Mouth; Mouth Neoplasms; Neovascularization, Pathologic; Signal Transduction; STAT3 Transcription Factor | 2016 |